1. Home
  2. CPRX
  3. CPRX News

Latest Catalyst Pharmaceuticals Inc. (CPRX) News on October 27, 2025

Kymera Therapeutics Stock Earns 92 RS Rating

Investor's Business Daily

5 months ago

Kymera Therapeutics Stock Earns 92 RS Rating

Associated Press Finance

6 months ago

Catalyst: Q1 Earnings Snapshot

Associated Press Finance

8 months ago

Catalyst: Q4 Earnings Snapshot

Argus Research

9 months ago

CPRX: Raising target price to $24.00

BridgeBio Pharma Stock Earns 87 RS Rating

Investor's Business Daily

9 months ago

BridgeBio Pharma Stock Earns 87 RS Rating

Arcellx Stock Earns 82 Relative Strength Rating

Investor's Business Daily

10 months ago

Arcellx Stock Earns 82 Relative Strength Rating

Share on Social Networks: